Morgan Stanley
-
-
-
-
-
-
-
Biohaven Announces Pricing of $250 Million Public Offering of Common Shares
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $146 at Morgan Stanley
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $55 at Morgan Stanley
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $44 at Morgan Stanley
-
-
-
-
-
-
-
Biohaven Pharmaceutical (BHVN) IPO Opens up 18%
-
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

